Colegio Médicos Postgraduados IMSS A.C.,
Original Article from The New England Journal of Medicine — An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1…
Original Article from The New England Journal of Medicine — An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1…
In this trial, high-risk nondiabetic relatives of patients with type 1 diabetes were randomly assigned to receive teplizumab (an…
Can we prevent autoimmune diseases such as #lupus, #Sjogrens, #RA, and #diabetes?: https://www.ncbi.nlm.nih.gov/pubmed?term=311…
Can we prevent autoimmune diseases such as #lupus, #Sjogrens, #RA, and #diabetes?: https://www.ncbi.nlm.nih.gov/pubmed?term=311…